{"disease":{"id":"choroid","name":"choroid"},"drugs":{"marketed":[{"drug_id":"prednisone","indication_name":"Diffuse posterior uveitis and choroiditis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltasone","generic_name":"prednisone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"ranibizumab-eqrn","indication_name":"Myopic Choroidal Neovascularization (mCNV)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"CIMERLI","generic_name":"RANIBIZUMAB-EQRN","company_name":"SANDOZ INC","drug_phase":"marketed","molecular_target":"","drug_class":"Vascular Endothelial Growth Factor Inhibitor [EPC]","quality_score":18,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone-phosphate","indication_name":"Diffuse posterior uveitis and choroiditis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dexamethasone Sodium Phosphate","generic_name":"dexamethasone phosphate","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Androgen receptor, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"verteporfin","indication_name":"Choroidal retinal neovascularization","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Visudyne","generic_name":"VERTEPORFIN","company_name":"Bausch Lomb Ireland","drug_phase":"marketed","molecular_target":"","drug_class":"Photoenhancer [EPC]","quality_score":10,"revenue":null,"mechanism":"Visudyne selectively binds to neovascular tissue, which is then activated by light to induce a phototoxic reaction."},{"drug_id":"fluocinolone-acetonide","indication_name":"Choroiditis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Derma-Smoothe/Fs","generic_name":"FLUOCINOLONE ACETONIDE","company_name":"Eurofarma","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"visudyne","indication_name":"Choroidal retinal neovascularization","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Visudyne","company_name":"Bayer","drug_phase":"discontinued","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"lucentis","indication_name":"Choroidal retinal neovascularization","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lucentis","company_name":"Santen Inc.","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor A","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"ranibizumab-nuna","indication_name":"Choroidal retinal neovascularization","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"BYOOVIZ","generic_name":"RANIBIZUMAB-NUNA","company_name":"SAMSUNG BIOEPIS CO LTD","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor A","drug_class":"","quality_score":null,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":8,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03753893","title":"Ocular Manifestations in Rheumatic Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":5000,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT03128463","title":"Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Xun Xu","has_results":false},{"nct_id":"NCT06431711","title":"Fundus Optical coheRence Tomography Angiography Evaluation for Small-vessel Health in Cerebral Small Vessel Disease","phase":"","overall_status":"RECRUITING","enrollment_count":2400,"lead_sponsor_name":"Zhejiang Provincial People's Hospital","has_results":false},{"nct_id":"NCT02307682","title":"Efficacy and Safety of RTH258 Versus Aflibercept - Study 1","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1775,"lead_sponsor_name":"Alcon Research","has_results":true},{"nct_id":"NCT05259605","title":"Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification","phase":"","overall_status":"RECRUITING","enrollment_count":1650,"lead_sponsor_name":"European Organisation for Research and Treatment of Cancer - EORTC","has_results":false},{"nct_id":"NCT03050268","title":"Familial Investigations of Childhood Cancer Predisposition","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT00919750","title":"Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors","phase":"","overall_status":"COMPLETED","enrollment_count":1258,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT04795206","title":"Natural Disease Progression in Participants With Choroideremia","phase":"","overall_status":"COMPLETED","enrollment_count":1178,"lead_sponsor_name":"Biogen","has_results":false},{"nct_id":"NCT02434328","title":"Efficacy and Safety of RTH258 Versus Aflibercept - Study 2","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1048,"lead_sponsor_name":"Alcon Research","has_results":true},{"nct_id":"NCT05222633","title":"Anti-VEGF in Real-world","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Wenbin Wei","has_results":false},{"nct_id":"NCT05639660","title":"Clinical Implication of Aflibercept in PCV Treatment in China","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT07496567","title":"A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":960,"lead_sponsor_name":"EyeBiotech Ltd.","has_results":false},{"nct_id":"NCT07440225","title":"A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":960,"lead_sponsor_name":"EyeBiotech Ltd.","has_results":false},{"nct_id":"NCT02875652","title":"Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU)","phase":"NA","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"Institut Curie","has_results":false},{"nct_id":"NCT01948830","title":"Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":650,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT05229237","title":"Conbercept for Polypoidal Choroidal Vasculopathy（START Study）","phase":"","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT01922102","title":"Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":457,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT06466018","title":"Research Into Diagnostic and Prognostic Molecular and Imaging Biomarkers of Ocular Disorders Associated With Neurovascular Deregulation: Biocor Cohort","phase":"NA","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Clinact","has_results":false},{"nct_id":"NCT02260687","title":"Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization","phase":"","overall_status":"COMPLETED","enrollment_count":353,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT01972789","title":"Comparison of Treatment Regimens Using Ranibizumab: Intensive (Resolution of Intra- and Sub-retinal Fluid) vs Relaxed (Resolution of Intra-retinal Fluid and/or Sub-retinal Fluid >200µm at the Foveal Centre)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":349,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT03584165","title":"Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":330,"lead_sponsor_name":"NightstaRx Ltd, a Biogen Company","has_results":false},{"nct_id":"NCT01846273","title":"Visual Outcome in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy (vPDT)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":321,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT03359551","title":"Natural History of the Progression of Choroideremia Study","phase":"","overall_status":"COMPLETED","enrollment_count":319,"lead_sponsor_name":"NightstaRx Ltd, a Biogen Company","has_results":false},{"nct_id":"NCT00006188","title":"Evaluation and Treatment of Patients With Inflammatory Eye Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT04790084","title":"Three-dimensional Choroidal Vascularity Index in Common Fundus Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Renmin Hospital of Wuhan University","has_results":false},{"nct_id":"NCT05934630","title":"Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors","phase":"","overall_status":"SUSPENDED","enrollment_count":300,"lead_sponsor_name":"Pediatric Brain Tumor Consortium","has_results":false},{"nct_id":"NCT02828215","title":"Advanced OCT and Adaptive Optics Imaging in Retinal Disease (The ACAD Study)","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Moorfields Eye Hospital NHS Foundation Trust","has_results":false},{"nct_id":"NCT06176352","title":"A Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":280,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT02484690","title":"A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":273,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT01908816","title":"An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":270,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT05494775","title":"Effect of Corona Virus on Intravitreal Injections","phase":"NA","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Benha University","has_results":false},{"nct_id":"NCT04439708","title":"Biomarkers and Choroidal Neovascularization","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":250,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT00511706","title":"Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":243,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT04101604","title":"Biomarkers of Common Eye Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":220,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT02068586","title":"Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":210,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","has_results":false},{"nct_id":"NCT04455399","title":"Time Efficiency Comparison of Two IntraVitreal Injection Techniques","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Peregrine Eye and Laser Institute","has_results":false},{"nct_id":"NCT04255524","title":"Choroidal Change on OCTA in Eyes With High Myopia","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT03244657","title":"Phase IV Clinical Trial (STAR Study) Extension Study of Conbercept Ophthalmic Injection for Treatment of Polypoid Choroidal Vasculopathy","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Chengdu Kanghong Biotech Co., Ltd.","has_results":false},{"nct_id":"NCT02034006","title":"A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT02707133","title":"Validation of a Virtual Model of Service Delivery for Choroidal Nevi","phase":"","overall_status":"COMPLETED","enrollment_count":199,"lead_sponsor_name":"Manchester University NHS Foundation Trust","has_results":false},{"nct_id":"NCT02162732","title":"Molecular-Guided Therapy for Childhood Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":186,"lead_sponsor_name":"Giselle Sholler","has_results":true},{"nct_id":"NCT07002372","title":"Effect of Video Viewing on Intravitreal Injection Experience","phase":"NA","overall_status":"RECRUITING","enrollment_count":182,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT07365371","title":"A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV)","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":174,"lead_sponsor_name":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT03496012","title":"Efficacy and Safety of BIIB111 for the Treatment of Choroideremia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":169,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT04773561","title":"Comparison of Posterior Ocular Changes Between Singleton Pregnancy and Multifetal Pregnancy.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":166,"lead_sponsor_name":"Khon Kaen University","has_results":false},{"nct_id":"NCT04891211","title":"Retinal Changes in Vitamin D Deficiency","phase":"NA","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Adiyaman University","has_results":false},{"nct_id":"NCT05666804","title":"Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":148,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT05662943","title":"Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV","phase":"","overall_status":"COMPLETED","enrollment_count":135,"lead_sponsor_name":"Kim's Eye Hospital","has_results":false},{"nct_id":"NCT03173950","title":"Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":133,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06442176","title":"Choroid In Coronary Artery Disease","phase":"","overall_status":"COMPLETED","enrollment_count":128,"lead_sponsor_name":"Bursa Yuksek Ihtisas Training and Research Hospital","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}